Therapeutic Potential of Checkpoint Inhibitors in Refractory Plasmablastic Lymphoma.
作者信息
Damlaj Moussab, Alzayed Mohammed, Alahmari Bader, Alhejazi Ayman, Alaskar Ahmed, Alzahrani Mohsen
机构信息
Division of Hematology and HSCT, Department of Oncology, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia; King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia; Division of Molecular Imaging and Nuclear Medicine, Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia.
出版信息
Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e559-e563. doi: 10.1016/j.clml.2019.06.008. Epub 2019 Jun 26.
PMID:31377210
Abstract
摘要
Zotero 插件